A long-term partnership behind a complex ecommerce system
How a long-term technology partnership supported the evolution of a complex medical device business – from early internal systems to a platform now being considered for wider rollout.
The Client
C-Pro Direct
Acquired by OrthoPediatrics (Nasdaq: KIDS)C-Pro Direct is a UK-based manufacturer and distributor of orthopaedic devices, supplying both the NHS and private providers, as well as direct-to-patient channels.
Their business combines multiple product lines, complex buyer types, and very different routes to market – from institutional procurement to individual patient sales.
Each channel brings its own expectations, workflows, and compliance requirements.
The Challenge
One platform, two very different buyers
C-Pro Direct needed a single platform that could support both institutional procurement and direct-to-consumer ecommerce – without compromising either.
On one side: purchase orders, approval chains, account hierarchies, and role-based pricing.
On the other: a straightforward ecommerce experience for individual patients.
Behind both sat the need for accurate inventory, reliable fulfilment, and systems that could support the operational demands of a growing medical device business.
This wasn’t something an off-the-shelf platform could handle without significant adaptation.
The Partnership
Two decades, one technology partner
Partnership begins
MediDev begins working with C-Pro Direct, initially developing internal systems to support clinical trials and early operational needs.
Clinical trial system
Custom software developed to track and manage a clinical trial – forming the foundation of the relationship.
First ecommerce platform
Initial nopCommerce-based ecommerce platform developed, tailored to the specific requirements of medical device distribution.
Platform evolution
Ongoing development introduces role-based pricing, PO workflows, account hierarchies, and ERP integration – each layer adding to the system’s capability.
Multi-channel maturity
A single platform supporting both NHS procurement teams and direct-to-patient ecommerce, with increasingly complex product and pricing structures.
Acquired by OrthoPediatrics Corp. (Nasdaq: KIDS)
The platform underwent acquisition-level technical due diligence.
Group-level consideration
The platform is now being evaluated for potential rollout across a wider group of companies.
What We Built
A platform shaped by real business problems
The platform wasn’t built in one phase. It evolved over time, responding to real operational needs as the business grew.
The Acquisition
Built to withstand scrutiny
Following acquisition by OrthoPediatrics Corp. (Nasdaq: KIDS), the platform underwent detailed technical due diligence.
Architecture, security, scalability, and operational reliability were all assessed as part of the process.
The platform passed.
What’s Next
From acquisition to group-wide consideration
OrthoPediatrics is now evaluating the MediDev-built platform for potential rollout across a wider group of companies.
As a listed business, this level of consideration reflects both the strength of the platform and the long-term partnership behind it.
Could your platform withstand acquisition-level scrutiny?
We can look at your systems and understand what's working and what isn't.
Start a conversation